Patient-reported outcomes could have a prognostic and predictive impact on care for multiple myeloma.A retrospective analysis ...

Panelists discuss the emotional and diagnostic journey of a multiple myeloma patient and his care partner, highlighting how ...

By MELINDA J. OVERSTREET for Glasgow News 1 In September 2023, he had been fighting a cold for weeks and weeks. His immune ...

Regeneron Pharmaceuticals has received accelerated FDA approval for Lynozyfic, a new bispecific antibody treatment for adults with relapsed or refractory multiple myeloma who have undergone at least ...

CT scans showed mass in thoracic spine 6–8, vertebral fracture, and left pleural effusion. This patient was diagnosed as IgA-λ MM at the DS IIIA stage (or ISS III, R-ISS III stage with EMD), ...

Researchers sought to determine risk of venous thromboembolism, based on SAVED and IMPEDE VTE scores, in patients with newly diagnosed multiple myeloma.

After his cancer diagnosis, author and editor Jonathan Gluck was told he had 18 months left to live. Here’s what “almost dying” taught him about how to live a happy, meaningful and regret-free life.

Immunotherapy Shows Promise As A ‘Potential Cure’ For Multiple Myeloma In a small study, a third of the participants with multiple myeloma, a common blood cancer which has up until now been deemed ...

251088 Introduction: Multiple myeloma (MM) is a hematological malignancy characterized by uncontrolled proliferation of plasma cells in the bone marrow. The diagnosis of MM is based on a broad range ...

251730 Introduction: Multiple myeloma (MM) is a plasma cell malignancy causing cytopenia, lytic bone lesions, and renal impairment. Diagnosis relies on CRAB criteria, serum protein electrophoresis, ...

Background: FDG-PET/TC and MRI are both imaging diagnostic tools adopted in diagnosis and/or response assessment in multiple myeloma (MM) which can be useful in smoldering, newly diagnosed as well in ...

It was recently presented at the 2025 COMy (Controversies in Multiple Myeloma) Congress. Conducted between November 2022 and December 2024, the study followed 37 consecutive patients with multiple ...